Back | Next |
home / stock / btai / btai message board
Subject | By | Source | When |
---|---|---|---|
Thoughts on where this is headed? | realfast95 | investorshub | 04/14/2023 9:48:20 PM |
MomentumIts trading | Alan Brown | investorshub | 04/14/2023 2:15:37 AM |
got some short data | lettruthringout | investorshub | 04/13/2023 11:21:17 PM |
short squeeze all day | frankyahoo | investorshub | 04/13/2023 10:21:48 PM |
$BTAI Have a look at this | realfast95 | investorshub | 04/13/2023 8:49:49 PM |
$BTAI The gaining last trade up | lettruthringout | investorshub | 04/13/2023 7:46:26 AM |
Time for this to show some returns | lettruthringout | investorshub | 04/13/2023 4:39:53 AM |
$BTAI MomentumIts trading last trade up | realfast95 | investorshub | 04/12/2023 11:20:36 PM |
MomentumIts now last up | realfast95 | investorshub | 04/12/2023 8:47:18 PM |
$BTAI Lets go go go go... Up up and away we go. | realfast95 | investorshub | 04/12/2023 8:09:43 AM |
Price now | realfast95 | investorshub | 04/11/2023 3:28:40 PM |
Price gaining | MDizzle | investorshub | 04/11/2023 1:49:32 PM |
Have a look at this | realfast95 | investorshub | 04/10/2023 8:00:41 PM |
Price now last up | lettruthringout | investorshub | 04/10/2023 2:19:47 PM |
$BTAI Have a look at this | realfast95 | investorshub | 04/10/2023 10:58:15 AM |
best news of the day | realfast95 | investorshub | 04/09/2023 8:01:41 PM |
$BTAI MomentumIts now up | lettruthringout | investorshub | 04/08/2023 11:33:25 AM |
$BTAI we got news | realfast95 | investorshub | 04/08/2023 9:41:02 AM |
BioXcel Therapeutics to Ring Nasdaq Stock Market Closing | MDizzle | investorshub | 02/21/2023 12:49:03 PM |
Chugging down due to hawkish fed | Alan Brown | investorshub | 02/10/2023 1:09:07 AM |
News, Short Squeeze, Breakout and More Instantly...
BioXcel Therapeutics Inc. Company Name:
BTAI Stock Symbol:
NASDAQ Market:
BioXcel Therapeutics Inc. Website:
Study achieved its objective and demonstrated no evidence of tachyphylaxis, tolerance, or withdrawal with 180 mcg dose (highest approved dose) For each episode occurring over seven days, a reduction in agitation was observed and no serious adverse events were reported following treatmen...
NEW HAVEN, Conn., May 28, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology, today announced that CEO Vimal Mehta, Ph.D., will present at the Jef...
NEW HAVEN, Conn., May 21, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology, today announced that Rob Risinger, M.D., Chief Medical Officer ...